How to Read a Certificate of Analysis (COA)

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is a document issued by an independent third-party testing laboratory that certifies a specific batch of compound meets defined quality standards. For research-grade peptides, the COA provides the primary evidence that the compound in a given vial is what it claims to be, at the stated purity level, and free from specified contaminants. It is the critical quality control document that separates verified research-grade material from uncharacterised compounds.

At Novahelix, COAs are issued per stocked lot from testing facilities with WHO/GMP and ISO 9001:2008 certification. When a new batch of any compound is stocked, a new COA is generated from that specific batch. COAs are available on request per lot number and are updated whenever a new batch is loaded to the Novahelix inventory.

Section 1 — HPLC Purity

HPLC purity is typically the first and most prominent figure on any peptide COA. HPLC stands for High-Performance Liquid Chromatography — an analytical technique that separates compounds based on their chemical properties and quantifies each component in a mixture.

How HPLC works: The peptide sample is dissolved in a mobile phase solvent and injected into a column packed with a stationary phase material (typically a reverse-phase C18 silica matrix for peptide analysis). Under high pressure, the mobile phase carries the sample through the column. Different compounds interact differently with the stationary phase — compounds with greater affinity for the stationary phase take longer to traverse the column and elute later. This time-based separation is recorded as a chromatogram.

The chromatogram: The output of an HPLC analysis is a graph plotting UV absorbance (typically measured at 214 nm, which detects peptide bonds) on the y-axis against time (retention time) on the x-axis. Each peak in the chromatogram represents a compound or impurity present in the sample.

Purity calculation: Purity % = (area of main peak ÷ total area of all peaks) × 100%. The area under each peak is proportional to the quantity of that compound present. A pure sample produces one dominant peak; impurities appear as additional smaller peaks.

What to look for: The main peak should be sharp, symmetrical, and clearly dominant over any secondary peaks. Small shoulder peaks or peak tailing indicate the presence of structurally similar impurities or degradation products. Novahelix stocks compounds with purity in the range of 98.6–99.5% HPLC. This range is considered research-grade standard; purity below 98% may introduce confounding variables in sensitive biological assays.

Retention time: The main peak should elute at the retention time expected for that specific peptide under the stated chromatographic conditions. A shift in retention time from the reference standard suggests a structural difference in the compound — either a synthesis error or degradation product.

Section 2 — Mass Spectrometry (Identity Confirmation)

While HPLC purity quantifies what proportion of the sample is a single compound, it cannot confirm the identity of that compound. Two peptides with similar polarity could co-elute at the same retention time and be indistinguishable by UV detection alone. Mass spectrometry (MS) provides identity confirmation that HPLC cannot.

How mass spectrometry works: Mass spectrometry measures the mass-to-charge ratio (m/z) of ionised molecules. For peptide analysis, electrospray ionisation mass spectrometry (ESI-MS) is the standard technique. ESI ionises the peptide at ambient conditions, producing multiply charged ions — written as [M+nH]n+, where M is the molecular mass, n is the charge state, and H is a proton. Multiple charge states are typically observed simultaneously for peptides.

Identity confirmation logic: The molecular formula of each peptide is precisely known from its sequence. From this, the expected m/z values for each charge state can be calculated. If the observed m/z values from the mass spectrum match the calculated values (within the instrument's mass accuracy, typically ±0.5 Da for unit-resolution instruments), identity is confirmed. A well-formatted COA will state: "observed m/z = X, calculated m/z = X, result: CONFIRMED."

Why mass spec matters beyond HPLC: HPLC cannot distinguish between structurally related impurities that happen to have the same molecular weight as the target peptide. Mass spec can, because even single amino acid substitutions or modifications change the molecular mass detectably. The combination of HPLC purity and mass spec identity confirmation provides robust quality verification.

Section 3 — Endotoxin Testing (LAL Test)

Endotoxins are lipopolysaccharides (LPS) derived from the outer membrane of gram-negative bacteria. Even trace quantities of endotoxin can trigger inflammatory responses in biological assay systems — stimulating cytokine release, activating macrophages, and confounding any assay that involves immune cell biology. For cell-based or in vivo research, endotoxin contamination is a common and serious source of experimental error.

The LAL test: Endotoxin testing in research-grade peptides uses the Limulus Amebocyte Lysate (LAL) assay, derived from the blood of horseshoe crabs (Limulus polyphemus). The amebocyte lysate undergoes a coagulation reaction specifically in the presence of endotoxin, providing an extremely sensitive and specific detection method. Results are expressed in Endotoxin Units per milligram (EU/mg).

Acceptable levels: For general research-grade peptides, the accepted standard is <10 EU/mg. For cell-based assays involving macrophages, dendritic cells, or other LPS-sensitive cell types, researchers often require <1 EU/mg. Novahelix COAs state either a specific EU/mg value or "below detection threshold" for the LAL assay, depending on the testing laboratory's detection limit for each batch.

Section 4 — Sterility

Lyophilised research peptides supplied in sealed vials are manufactured under aseptic conditions. Sterility testing may reference USP General Chapter <71> (Sterility Tests) or equivalent pharmacopoeial standards, and verifies the absence of viable aerobic and anaerobic bacteria and fungi in the sealed vial. This is particularly relevant for any research protocol involving cell culture or in vivo administration routes where microbial contamination would compromise results or confound biological measurements.

Section 5 — TFA Content

Trifluoroacetic acid (TFA) is a standard reagent used in reverse-phase HPLC purification of synthetic peptides. It acts as an ion-pairing agent that improves peak resolution and separation efficiency. However, TFA remains in the purified peptide product as a trifluoroacetate counter-ion salt and is not easily removed without additional processing steps.

TFA is cytotoxic to mammalian cells at sufficient concentrations, making TFA content an important parameter for cell-based research assays. The COA should state the TFA content of the batch, typically expressed as a percentage of total mass. For research-grade peptides, TFA content below 0.1% is generally considered acceptable for most cell-based protocols, though researchers working with particularly TFA-sensitive assay systems may require lower levels.

Other COA Elements to Verify

• Batch/Lot number: The single most important identifier. Every legitimate COA is tied to a specific production batch. Cross-reference the lot number on the COA with the lot number on your vial label to confirm they match. Do not accept a generic COA without a specific lot number.
• Compound name and CAS number: Confirm the compound name and Chemical Abstracts Service registry number match the compound ordered.
• Molecular formula and molecular weight: Should match published values for the stated peptide sequence.
• Physical description: Research-grade lyophilised peptides should be described as a white or off-white lyophilised powder. GHK-Cu may appear as a light blue powder due to copper complexation. Discolouration or unusual appearance warrants investigation before use.
• Testing laboratory name and accreditation: The issuing laboratory should be independently certified; COAs from non-accredited internal testing carry less evidentiary weight than those from ISO-certified third-party laboratories.

Verifying Your COA

Reputable peptide suppliers make COA documents available on request per lot number. The correct process is: note the lot number printed on your vial label, request the COA for that specific lot from the supplier, and verify that all parameters described above meet the required standards for your research protocol. Do not accept a COA that is not tied to the specific lot number of the vials you have received.

Novahelix provides COA documentation per lot on request. Contact hello@novahelix.com.au with your order details and lot number to obtain the relevant documentation.